Trauma is one of six National Programmes of Care (NPoCs) overseeing the commissioning of specialised and highly specialised services.
The role of the NPoC is to provide leadership and oversight of the development and delivery of a comprehensive work programme that achieves demonstrable improvements in the quality, equity, value and outcomes of commissioned specialised services.
The Trauma NPoC covers specialised services in traumatic injury, orthopaedics, head and neck and rehabilitation. It consists of an NPoC Board and seven Clinical Reference Groups (CRGs) as follows:
- Rehabilitation and Disability (D01)
- Major Trauma (D02)
- Spinal Services (D03)
- Neurosciences (D04)
- Adult Critical Care (D05)
- Specialised Ear and Ophthalmology Services (D06)
- Specialised Pain (D07)
CRGs provide clinical advice and leadership on the specialised services in the Trauma NPoC. These groups of clinicians, commissioners, public health experts, patients and carers use their specific knowledge and expertise to advise NHS England on the best ways that specialised services should be provided.
CRGs lead on the development of clinical commissioning policies, service specifications and quality standards. They also provide advice on innovation, horizon scanning, service reviews and guide work to reduce variation and deliver increased value. CRGs, through their Patient and Public Voice (PPV) members, also help ensure that any changes to the commissioning of specialised services involve patients and the public.
Chair and membership of the Trauma NPoC Board
Chair: Robert Cornall, Regional Director of Specialised Commissioning North
Co-Chair: Paul May, Liverpool
- National Programme of Care Senior Manager: Jacquie Kemp
- National Programme of Care Manager: Helen Morrison
- Commissioning Manager, Highly Specialised Commissioning: Nicola Symes
- Regional Programme of Care Manager North: David Stockdale
- Regional Programme of Care Manager Midlands & East: Carolyn Young
- Regional Programme of Care Manager London: Victoria Osborne-Smith
- Regional Programme of Care Manager South: Katharine Young
- Medical Director, Specialised Commissioning (London): Michael Marsh
- Regional Nursing Director: Susan Bowler
- Finance Lead: Peter Davies
- PPV member: Jayne Hidderley
- PPV member: Vacancy – If you are interested in applying for this vacancy please email firstname.lastname@example.org for more information.
- CCG Lead: Beverley Flowers
- Medicines / Pharmacy Advisor: Paul McManus
- Public Health Lead: Robert Wilson
The ‘products’ of commissioning are the tools used by the 10 Hub Commissioning Teams to contract services on an annual basis and are listed under each CRG. A small number of products – service specifications and policies – are listed here as they fall within the scope of this NPoC but do not logically sit with a single CRG.
Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe both core and developmental service standards. Core standards are those that all funded providers should be able to demonstrate, with developmental standards being those which may require further changes in practice over time to provide excellence in the field.
The following service specifications fall within the scope of this NPoC:
A commissioning policy is a document that defines access to a service for a particular group of patients. A NICE Technology Appraisal Guideline on the same topic will replace, or be incorporated into, a commissioning policy as appropriate. These are important documents that are developed to ensure consistency in access to treatments nationwide.
The following policies fall within the scope of this NPoC:
Not routinely commissioned
- Autologous chrondrocyte implantation for osteochondral lesions of the talus (adults)
- Hyperbaric oxygen therapy for malignant otitis externa (all ages)
- Hyperbaric oxygen therapy for necrotising soft tissue infections (adults)
- Hyperbaric oxygen therapy for soft tissue radiation damage in patients with a history of pelvic irradiation for malignant disease (all ages)
- Hyperbaric oxygen therapy for carbon monoxide poisoning (all ages)